2017 Annual Meeting
*Registration Opening Soon!
Hyatt Regency Orlando
9801 International Drive
Orlando, FL 32819
A block of rooms has been reserved at the Hyatt Regency Orlando for the 2017 CGA Annual Meeting attendees at a discounted rate of $215.00 plus tax. The discounted hotel rate is available through Thursday, September 28. After September 28, rooms are subject to availability and prevailing rates.
To book your room, please visit the CGA Annual Meeting dedicated website clicking here. You can also book your room by calling the hotel directly at 888-421-1442 and reference the CGA Annual Meeting when booking your room.
For information on sponsorship opportunities or exhibiting at the conference please email us by clicking here.
Submit An Abstract!
2017 Annual Meeting
The 2017 CGA Annual Meeting is being held October 20-21 at the Hyatt Regency Orlando. The meeting will follow the America College of Gastroenterology (ACG) Annual Scientific Meeting and Postgraduate Course - World Congress of Gastroenterology (WCOG) being held October 13-18, 2017 and The American Society of Human Genetics being held October 17-21, 2017 in Orlando, FL. The Annual Meeting is designed to keep clinicians and scientists up-to-date on new developments in hereditary colorectal cancer research, including implications in the prevention, diagnosis, and treatment of patients with the hereditary colorectal cancer syndromes. The 21st Annual Meeting of CGA will present supportive information and updates on hereditary colorectal cancer research for clinicians. The meeting will be directed to colorectal surgeons, medical oncologists, gastroenterologists, researchers, geneticists, nurses, colorectal cancer registry coordinators, genetic counselors, psychologists and other health care professionals involved in the care of individuals with hereditary colorectal cancer. Complete registration will be available in the next upcoming week. For a tentative agenda, click here.
Who Should Attend
The 2017 CGA Annual Meeting will be directed to all caregivers and researchers interested in hereditary colorectal cancer syndromes, including colorectal surgeons, medical oncologists, gastroenterologists, geneticists, nurses, colorectal cancer registry coordinators, genetic counselors, psychologists and other professionals involved in the care of individuals with hereditary colorectal cancer.
- Summarize recent research on the basic biology of colorectal cancer pathogenesis, including new findings on modifiers of the hereditary phenotypes, and describe potential implications for clinical practice
- Implement new approaches to screening and preventing colorectal cancers, highlighting the evidence-base for new diagnostics, devices, and pharmaceuticals
- Describe the impact of newly discovered genes and the use of recently introduced gene panels to diagnose and manage hereditary colorectal cancer syndromes
- Institute use of clinical and genetic modifiers of the hereditary cancer risk in clinical practice
- List the surgical approaches to hereditary colorectal cancer syndromes for both treatment and prophylaxis and describe patient factors that guide surgical decision-making
- Define the changing care models for diagnosis and management of various hereditary cancer syndromes